{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "PARK2 C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is critical for mitophagy, and the C289G mutant fails to redistribute to damaged mitochondria, causing mitophagy defects linked to Parkinson's disease.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Assess assay relevance to disease mechanism",
          "extracted_paper_info": "The study directly examines Parkin's role in mitophagy and its functional impairment in the C289G mutant.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "The study compares the C289G mutant to wild-type Parkin and evaluates rescue with HSJ1a, but does not explicitly state the use of both normal and abnormal controls.",
          "judgment": "No"
        },
        {
          "step_name": "Step 3b: Accepted assay methodology",
          "extracted_paper_info": "The assay (mitophagy function analysis) is a standard method in Parkinson's research, validated by prior studies on Parkin's role in mitochondrial quality control.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4a: Statistical analyses",
          "extracted_paper_info": "The study reports functional defects in the mutant but does not quantify OddsPath or provide statistical metrics for pathogenicity.",
          "judgment": "No"
        },
        {
          "step_name": "Step 4b: Control variant counts",
          "extracted_paper_info": "The study uses 1-2 control variants (wild-type Parkin and rescued mutant) but does not explicitly report the total number of benign/pathogenic controls.",
          "judgment": "No"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "No OddsPath value is provided, but the variant's functional impairment is directly tied to disease mechanisms.",
          "judgment": "Max PS3_supporting"
        }
      ],
      "strength": "PS3_supporting",
      "conclusion": "The PARK2 C289G variant is classified as pathogenic based on its direct role in impairing mitophagy, a critical process in Parkinson's disease, with functional evidence meeting ACMG criteria for PS3_supporting strength."
    }
  ]
}